I agree that this site is using cookies. You can find further informations here.
X
Nakagawa, Miyuki
211  results:
Search for persons X
?
1

Assessment of Macrovascular Invasion in Advanced Hepatocell..:

Inoue, Masanori ; Ogasawara, Sadahisa ; Kobayashi, Kazufumi...
Liver Cancer.  , 2024
Link: https://doi.org/10.1159/..
 
?
2

Clinical risk factors for portal hypertension-related compl..:

Fujiwara, Kisako ; Kondo, Takayuki ; Fujimoto, Kentaro...
Journal of Gastroenterology.  59 (2024)  6 - p. 515-525 , 2024
Link: https://doi.org/10.1007/..
 
?
3

SAT-335 Pathological dynamics and clinical implications of ..:

Izai, Ryo ; Ogasawara, Sadahisa ; Akatsuka, Teppei...
Journal of Hepatology.  80 (2024)  - p. S123-S124 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Hyperprogressive disease during atezolizumab plus bevacizum..:

Yumita, Sae ; Ogasawara, Sadahisa ; Nakagawa, Miyuki...
BMC Gastroenterology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
5

Potential of circulating receptor-interacting protein kinas..:

Kondo, Takayuki ; Fujimoto, Kentaro ; Fujiwara, Kisako...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
6

Cabozantinib for Advanced Hepatocellular Carcinoma in the L..:

Kanzaki, Hiroaki ; Ogasawara, Sadahisa ; Okubo, Tomomi...
Drugs - Real World Outcomes.  10 (2023)  4 - p. 513-520 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Miglustat, a glucosylceramide synthase inhibitor, mitigates..:

Iwanaga, Terunao ; Chiba, Tetsuhiro ; Nakamura, Masato...
Biochemical and Biophysical Research Communications.  642 (2023)  - p. 192-200 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Estimation of the effect of atezolizumab plus bevacizumab o..:

Kondo, Takayuki ; Fujiwara, Kisako ; Nakagawa, Miyuki...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

Use of ramucirumab for various treatment lines in real-worl..:

Kanogawa, Naoya ; Ogasawara, Sadahisa ; Maruta, Susumu...
BMC Gastroenterology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

A Serine Protease Inhibitor, Camostat Mesilate, Suppresses ..:

Iwata, Yasunobu ; Deng, Qinyuan ; Kakizoe, Yutaka...
International Journal of Molecular Sciences.  24 (2023)  21 - p. 15743 , 2023
Link: https://doi.org/10.3390/..
 
?
11

Durvalumab with or without tremelimumab combined with parti..:

Ogasawara, Sadahisa ; Koroki, Keisuke ; Makishima, Hirokazu...
BMJ Open.  12 (2022)  4 - p. e059779 , 2022
Link: https://doi.org/10.1136/..
 
?
12

Camostat mesilate, a serine protease inhibitor, exerts aqua..:

Kakizoe, Yutaka ; Nakagawa, Terumasa ; Iwata, Yasunobu...
Journal of Pharmacological Sciences.  150 (2022)  4 - p. 204-210 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Liver biopsy technique in the era of genomic cancer therapi..:

Ozeki, Yusuke ; Kanogawa, Naoya ; Ogasawara, Sadahisa...
International Journal of Clinical Oncology.  27 (2022)  9 - p. 1459-1466 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Effect of Atezolizumab plus Bevacizumab in Patients with He..:

Ogawa, Keita ; Kanzaki, Hiroaki ; Chiba, Tetsuhiro...
Journal of Cancer.  13 (2022)  8 - p. 2656-2661 , 2022
Link: https://doi.org/10.7150/..
 
?
15

Clinical effects and emerging issues of atezolizumab plus b..:

Nakagawa, Miyuki ; Inoue, Masanori ; Ogasawara, Sadahisa...
Cancer.  129 (2022)  4 - p. 590-599 , 2022
Link: https://doi.org/10.1002/..
 
1-15